{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:35:06Z","timestamp":1792103706362,"version":"4.4.0"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"33","license":[{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8,19]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>This study aimed to analyze and summarize the research hotspots and trends in neuroimaging biomarkers (NMBM) in Parkinson disease (PD) based on the Web of Science core collection database and provide new references for future studies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Literature regarding NMBM in PD from 1998 to 2022 was analyzed using the Web of Science core collection database. We utilized CiteSpace software (6.1R2) for bibliometric analyses of countries\/institutions\/authors, keywords, keyword bursts, references, and their clusters.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 339 studies were identified with a continually increasing annual trend. The most productive country and collaboration was the United States. The top research hotspot is PD cognitive disorder. NMBM and artificial intelligence medical imaging have been applied in the clinical diagnosis, differential diagnosis, treatment, and prognosis of PD. The trends in this field include research on T1 weighted structure magnetic resonance imaging in accordance with voxel-based morphometry, PD cognitive disorder, and neuroimaging features of Lewy body dementia and Alzheimer disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The development of NMBM in PD will be effectively promoted by drawing on international research hotspots and cutting-edge technologies, emphasizing international collaboration and institutional cooperation at the national level, and strengthening interdisciplinary research.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000030079","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T13:18:54Z","timestamp":1660915134000},"page":"e30079","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["A bibliometric analysis of neuroimaging biomarkers in Parkinson disease based on Web of Science"],"prefix":"10.1097","volume":"101","author":[{"given":"Xiao-Ling","family":"Li","sequence":"first","affiliation":[{"name":"Division of CT and MRI, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Xue","family":"Gao","sequence":"additional","affiliation":[{"name":"Graduate School of Heilongjiang University of Chinese Medicine, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinhong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Tuina, Acupuncture and Moxibustion, Shenzhen Jiuwei Chinese Medicine Clinic, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang","family":"Li","sequence":"additional","affiliation":[{"name":"Sanofi-Aventis China Investment Co., Ltd, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Na","family":"Cai","sequence":"additional","affiliation":[{"name":"Graduate School of Heilongjiang University of Chinese Medicine, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Wei","family":"Zhao","sequence":"additional","affiliation":[{"name":"MSD R&D (China) Co., Ltd, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Lan","family":"Gao","sequence":"additional","affiliation":[{"name":"Graduate School of Heilongjiang University of Chinese Medicine, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of CT and MRI, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China"},{"name":"Graduate School of Heilongjiang University of Chinese Medicine, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0256-9618","authenticated-orcid":false,"given":"Jinhuan","family":"Yue","sequence":"additional","affiliation":[{"name":"Department of Tuina, Acupuncture and Moxibustion, Shenzhen Jiuwei Chinese Medicine Clinic, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fcell.2020.00086","article-title":"Potential roles of exosomes in Parkinson\u2019s disease: from pathogenesis, diagnosis, and treatment to prognosis.","volume":"8","author":"Yu","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"R2-20250504","first-page":"733","article-title":"Current treatment strategies for Parkinson\u2019s disease.","volume":"79","author":"Sudmeyer","year":"2011","journal-title":"Fortschr Neurol Psychiatr"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1750-3639.2009.00369.x","article-title":"The epidemiology of dementia associated with Parkinson\u2019s disease.","volume":"20","author":"Aarsland","year":"2010","journal-title":"Brain Pathol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson\u2019s disease.","volume":"5","author":"De Lau","year":"2006","journal-title":"Lancet Neurol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","article-title":"The epidemiology of Parkinson\u2019s disease: risk factors and prevention.","volume":"15","author":"Ascherio","year":"2016","journal-title":"Lancet Neurol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/aje\/kwg068","article-title":"Incidence of Parkinson\u2019s disease: variation by age, gender, and race\/ethnicity.","volume":"157","author":"Van Den Eeden","year":"2003","journal-title":"Am J Epidemiol"},{"key":"R7-20250504","first-page":"133","article-title":"Is the cause of Parkinson\u2019s disease environmental or hereditary? Evidence from twin studies.","volume":"91","author":"Tanner","year":"2003","journal-title":"Adv Neurol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","article-title":"Parkinson\u2019s disease.","volume":"363","author":"Samii","year":"2004","journal-title":"Lancet"},{"key":"R9-20250504","first-page":"13","article-title":"Familial Parkinson\u2019s disease. \u03b1-Synuclein and parkin.","volume":"86","author":"Mizuno","year":"2001","journal-title":"Adv Neurol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1474-4422(11)70152-1","article-title":"Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.","volume":"10","author":"Iranzo","year":"2011","journal-title":"Lancet Neurol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.sleep.2018.12.020","article-title":"Brain cholinergic alterations in idiopathic REM sleep behaviour disorder: a PET imaging study with (18)F-FEOBV.","volume":"58","author":"Bedard","year":"2019","journal-title":"Sleep Med"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.dadm.2019.04.002","article-title":"Factors affecting the harmonization of disease-related metabolic brain pattern expression quantification in [18F]FDG-PET (PETMETPAT).","volume":"11","author":"Kogan","year":"2019","journal-title":"Alzheimers Dement (Amst)"},{"key":"R13-20250504","first-page":"e0165540e0165540","article-title":"Progression of regional microstructural degeneration in Parkinson\u2019s disease: a multicenter diffusion tensor imaging study.","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/mds.26606","article-title":"Aberrant nigral diffusion in Parkinson\u2019s disease: a longitudinal diffusion tensor imaging study.","volume":"31","author":"Loane","year":"2016","journal-title":"Mov Disord"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neulet.2016.09.011","article-title":"A longitudinal study of neuromelanin-sensitive magnetic resonance imaging in Parkinson\u2019s disease.","volume":"633","author":"Matsuura","year":"2016","journal-title":"Neurosci Lett"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s12264-017-0138-x","article-title":"Region-specific iron measured by MRI as a biomarker for Parkinson\u2019s disease.","volume":"33","author":"Guan","year":"2017","journal-title":"Neurosci Bull"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.3174\/ajnr.A4447","article-title":"Longitudinal study of gray matter changes in Parkinson disease.","volume":"36","author":"Jia","year":"2015","journal-title":"AJNR Am J Neuroradiol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/bs.acc.2019.12.001","article-title":"New markers in Parkinson\u2019s disease.","volume":"96","author":"Bougea","year":"2020","journal-title":"Adv Clin Chem"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuint.2013.06.005","article-title":"Biomarkers in Parkinson\u2019s disease (recent update).","volume":"63","author":"Sharma","year":"2013","journal-title":"Neurochem Int"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3389\/fnagi.2018.00305","article-title":"Recent advances in biomarkers for Parkinson\u2019s disease.","volume":"10","author":"He","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/asi.20317","article-title":"CiteSpace II: detecting and visualizing emerging trends and transient patterns in scientific literature.","volume":"57","author":"Chen","year":"2006","journal-title":"J Am Soc Inf Sci Tec"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"620555","DOI":"10.3389\/fnins.2020.620555","article-title":"Global trends and performances of magnetic resonance imaging studies on acupuncture: a bibliometric analysis.","volume":"14","author":"Zhang","year":"2020","journal-title":"Front Neurosci"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"717192","DOI":"10.3389\/fphar.2021.717192","article-title":"Current state and future directions of intranasal delivery route for central nervous system disorders: a scientometric and visualization analysis.","volume":"12","author":"Wu","year":"2021","journal-title":"Front Pharmacol"},{"key":"R24-20250504","first-page":"e0223994e0223994","article-title":"Visualizing a field of research: a methodology of systematic scientometric reviews.","volume":"14","author":"Chen","year":"2019","journal-title":"PLoS One"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/asi.21309","article-title":"The structure and dynamics of co citation clusters: a multiple perspective co-citation analysis.","volume":"61","author":"Chen","year":"2019","journal-title":"J Am Soc Inf Sci Tec"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: VOSviewer, a computer program for bibliometric mapping.","volume":"84","author":"van Eck","year":"2010","journal-title":"Scientometrics"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s11192-010-0173-0","article-title":"Automatic term identification for bibliometric mapping.","volume":"82","author":"van Eck","year":"2010","journal-title":"Scientometrics"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease.","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium.","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease.","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"R31-20250504","first-page":"1277","article-title":"Association of cerebrospinal fluid \u03b2-amyloid 1-42, T-tau, P-tau181, and \u03b1-synuclein levels with clinical features of drug-naive patients with early Parkinson disease.","volume":"70","author":"Kang","year":"2013","journal-title":"JAMA Neurol"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/jamaneurol.2015.0703","article-title":"New clinical subtypes of Parkinson disease and their longitudinal progression: a prospective cohort comparison with other phenotypes.","volume":"72","author":"Fereshtehnejad","year":"2015","journal-title":"JAMA Neurol"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/NEN.0b013e3182805c72","article-title":"Submandibular gland biopsy for the diagnosis of Parkinson disease.","volume":"72","author":"Beach","year":"2013","journal-title":"J Neuropathol Exp Neurol"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1750-3639.2009.00370.x","article-title":"Biomarkers for cognitive impairment in Parkinson disease.","volume":"20","author":"Shi","year":"2010","journal-title":"Brain Pathol"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1212\/01.wnl.0000338632.00552.cb","article-title":"Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.","volume":"72","author":"Aarsland","year":"2009","journal-title":"Neurology"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.neubiorev.2012.01.004","article-title":"Using support vector machine to identify imaging biomarkers of neurological and psychiatric disease: a critical review.","volume":"36","author":"Orr\u00f9","year":"2012","journal-title":"Neurosci Biobehav Rev"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s12264-014-1472-x","article-title":"Brain network markers of abnormal cerebral glucose metabolism and blood flow in Parkinson\u2019s disease.","volume":"30","author":"Peng","year":"2014","journal-title":"Neurosci Bull"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/mds.21933","article-title":"Abnormal metabolic networks in atypical parkinsonism.","volume":"23","author":"Eckert","year":"2008","journal-title":"Mov Disord"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/jcbfm.2011.166","article-title":"Abnormal metabolic brain networks in a nonhuman primate model of parkinsonism.","volume":"32","author":"Ma","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.tins.2009.06.003","article-title":"Metabolic brain networks in neurodegenerative disorders: a functional imaging approach.","volume":"32","author":"Eidelberg","year":"2009","journal-title":"Trends Neurosci"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"S725","DOI":"10.1002\/mds.22541","article-title":"Metabolic networks for assessment of therapy and diagnosis in Parkinson\u2019s disease.","volume":"24","author":"Hirano","year":"2009","journal-title":"Mov Disord"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00234-017-1821-3","article-title":"Abnormal metabolic brain network associated with Parkinson\u2019s disease: replication on a new European sample.","volume":"59","author":"Tomse","year":"2017","journal-title":"Neuroradiology"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejmp.2017.01.018","article-title":"The effect of 18F-FDG-PET image reconstruction algorithms on the expression of characteristic metabolic brain network in Parkinson\u2019s disease.","volume":"41","author":"Tomse","year":"2017","journal-title":"Phys Med"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/mds.26302","article-title":"Reproducibility of a parkinsonism-related metabolic brain network in non-human primates: a descriptive pilot study with FDG PET.","volume":"30","author":"Ma","year":"2015","journal-title":"Mov Disord"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/mds.25975","article-title":"Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts.","volume":"29","author":"Kraemmer","year":"2014","journal-title":"Mov Disord"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/mds.28348","article-title":"Automated categorization of parkinsonian syndromes using magnetic resonance imaging in a clinical setting.","volume":"36","author":"Chougar","year":"2021","journal-title":"Mov Disord"},{"issue":"Suppl 1","key":"R47-20250504","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.parkreldis.2017.07.033","article-title":"Neuropathology of Parkinson disease.","volume":"46","author":"Dickson","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","article-title":"100 years of Lewy pathology.","volume":"9","author":"Goedert","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease.","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","article-title":"Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson\u2019s disease: a case-control study.","volume":"7","author":"Healy","year":"2008","journal-title":"Lancet Neurol"},{"key":"R51-20250504","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ajhg.2011.06.001","article-title":"VPS35 mutations in Parkinson disease.","volume":"89","author":"Vilari\u00f1o-G\u00fcell","year":"2011","journal-title":"Am J Hum Genet"},{"key":"R52-20250504","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ajhg.2011.06.008","article-title":"A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease.","volume":"89","author":"Zimprich","year":"2011","journal-title":"Am J Hum Genet"},{"key":"R53-20250504","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ajhg.2011.08.009","article-title":"Translation initiator EIF4G1 mutations in familial Parkinson disease.","volume":"89","author":"Chartier-Harlin","year":"2011","journal-title":"Am J Hum Genet"},{"key":"R54-20250504","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/hmg\/ddt570","article-title":"DNAJC13 mutations in Parkinson disease.","volume":"23","author":"Vilari\u00f1o-G\u00fcell","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R55-20250504","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S1474-4422(14)70266-2","article-title":"CHCHD2 mutations in autosomal dominant late-onset Parkinson\u2019s disease: a genome-wide linkage and sequencing study.","volume":"14","author":"Funayama","year":"2015","journal-title":"Lancet Neurol"},{"key":"R56-20250504","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/mds.26662","article-title":"Biomarkers for dementia and mild cognitive impairment in Parkinson\u2019s disease.","volume":"31","author":"Delgado-Alvarado","year":"2016","journal-title":"Mov Disord"},{"key":"R57-20250504","doi-asserted-by":"crossref","first-page":"e12870","DOI":"10.2196\/12870","article-title":"Functional magnetic resonance imaging biomarkers predicting cognitive progression in Parkinson disease: protocol for a prospective longitudinal cohort study.","volume":"8","author":"Hanna-Pladdy","year":"2019","journal-title":"JMIR Res Protoc"},{"key":"R58-20250504","doi-asserted-by":"crossref","first-page":"773","DOI":"10.21037\/atm.2019.11.26","article-title":"Use of radiomic features and support vector machine to distinguish Parkinson\u2019s disease cases from normal controls.","volume":"7","author":"Wu","year":"2019","journal-title":"Ann Transl Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030079","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:47:08Z","timestamp":1746334028000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,19]]},"references-count":58,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000030079","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,19]]}}}